Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Stickel

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Gastroenterology|June 19, 2016
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From PatientsAndreas Teufel, Timo Itzel, Wiebke Erhart, et al.
Hepatology (Baltimore, Md.)|October 31, 2015
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infectionMaria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosisStefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Inflammatory Bowel Diseases|July 28, 2021
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesisHong-Lei Weng, Yan Liu, Jia-Lin Chen, et al.
Hepatology International|June 2, 2021
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver diseaseRafael Paternostro, Katharina Staufer, Stefan Traussnigg, et al.
Alcoholism, Clinical and Experimental Research|April 16, 2015
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational studyJohn B Whitfield, Khairunnessa Rahman, Paul S Haber, et al.
Nature Communications|October 10, 2018
Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic controlMario Brosch, Kathrin Kattler, Alexander Herrmann, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Gastroenterology|June 19, 2016
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From PatientsAndreas Teufel, Timo Itzel, Wiebke Erhart, et al.
Hepatology (Baltimore, Md.)|October 31, 2015
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infectionMaria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosisStefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Inflammatory Bowel Diseases|July 28, 2021
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesisHong-Lei Weng, Yan Liu, Jia-Lin Chen, et al.
Hepatology International|June 2, 2021
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver diseaseRafael Paternostro, Katharina Staufer, Stefan Traussnigg, et al.
Alcoholism, Clinical and Experimental Research|April 16, 2015
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational studyJohn B Whitfield, Khairunnessa Rahman, Paul S Haber, et al.
Nature Communications|October 10, 2018
Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic controlMario Brosch, Kathrin Kattler, Alexander Herrmann, et al.
Pageof 17